Terms: = Lymphoma AND H3F3B, H3_3A, 3021, ENSG00000132475, P84243, H3_3B, MGC87783, MGC87782, H3F3 AND Treatment
2 results:
1. Formyl peptide receptor-2 is decreased in foetal growth restriction and contributes to placental dysfunction.
Lappas M; McCracken S; McKelvey K; Lim R; James J; Roberts CT; Fournier T; Alfaidy N; Powell KL; Borg AJ; Morris JM; Leaw B; Singh H; Ebeling PR; Wallace EM; Parry LJ; Dimitriadis E; Murthi P
Mol Hum Reprod; 2018 Feb; 24(2):94-109. PubMed ID: 29272530
[TBL] [Abstract] [Full Text] [Related]
2. Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma.
Moreau P; Karamanesht II; Domnikova N; Kyselyova MY; Vilchevska KV; Doronin VA; Schmidt A; Hulin C; Leleu X; Esseltine DL; Venkatakrishnan K; Skee D; Feng H; Girgis S; Cakana A; van de Velde H; Deraedt W; Facon T
Clin Pharmacokinet; 2012 Dec; 51(12):823-9. PubMed ID: 23018466
[TBL] [Abstract] [Full Text] [Related]
